Exercise booster? CoQ10 may help kidney patients build muscle
NCT ID NCT05422534
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding CoQ10 (a supplement that supports cell energy) to high-intensity interval training can help people with end-stage kidney disease build muscle and improve physical function. 156 adults on dialysis will be assigned to exercise alone or exercise plus CoQ10. The goal is to see if targeting mitochondria can make exercise more effective for preventing frailty.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 156 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2023
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Subjects age 18 to 75 years * On thrice-weekly chronic hemodialysis for at least 6 months (only applicable for patients with ESRD on maintenance hemodialysis). * Clinically stable, adequately dialyzed (single-pool Kt/V \>1.2) thrice weekly, for at least 3 consecutive months prior to the study (only applicable for patients with ESRD on maintenance hemodialysis) Exclusion Criteria: * Body mass index \> 35 mg/kg2 * History of functional transplant less than 6 months prior to study * Use of immunosuppressive drugs within 1 month prior to study * Active connective tissue disease * Acute infectious disease within 1 month prior to study * AIDS (HIV seropositivity is not an exclusion criterion) * Acute myocardial infarction or cerebrovascular event within 3 months * Uncontrolled blood pressure * New or worsening mitral regurgitation murmur * Hypotension, bradycardia, or tachycardia * Prolonged ongoing (greater than 20 minutes) angina at rest * Angina at rest with transient ST changes greater than 0.05 mV on ECG * Sustained ventricular tachycardia on ECG * Elevated cardiac enzymes (e.g., troponin Tor I greater than 0.1mg/ml) * Advanced liver disease, with a modified Child-Turcotte-Pugh score equal or greater than 10. * Gastrointestinal dysfunction requiring parental nutrition * Active malignancy excluding basal cell carcinoma of the skin * Ejection fraction less than 30% * Pre-dialysis potassium repeatedly higher than 5.5 mmol/L (confirmed on a repeated blood draw) * Anticipated live donor kidney transplant * History of poor adherence to hemodialysis or medical regimen * Inability to provide consent * Subjects with cardiac pacemaker, artificial heart valve, any metallic implant, permanent tattoo, or any retained foreign metallic bodies. * Inability to perform exercise * Contraindication for exercise such as electrolyte abnormalities, uncontrolled arrhythmias, or pulmonary congestion.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End stage renal disease are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of California Davis Health
NOT_YET_RECRUITINGSacramento, California, 95817, United States
-
Vanderbilt University Medical Center-GCRC
RECRUITINGNashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can tweaking dialysis sodium flush out hidden salt and protect blood vessels?
- Can dialysis filters improve kidney recovery? a data review seeks answers
- Can a damaged kidney change how a Weight-Loss drug works?
- Dialysis patients may fight frailty with home video workouts
- Lab-Grown vessels could revolutionize dialysis access
- Can a biological graft improve dialysis access?